TEM Tempus Sof foyda bo'yicha sotuv rentabelligi

TEM (Tempus AI Inc) - kompaniyaning tovar belgisi

Tempus AI, Inc (TEM) sun'iy intellekt yordamida DNKni tahlil qilish va sog'liqni saqlash gigantlariga noyob tahliliy ma'lumotlarni sotish orqali shaxsiylashtirilgan davolash segmentini egallamoqda. Sof foyda marjasi kliniklarda onkologiya platformasining joriy etilishi va obunalar miqdorining kengayishi natijasida yuzaga kelgan burilish nuqtasini aks ettiradi. O'sish Big Pharma bilan tuzilgan shartnomalar hisobiga ta'minlanmoqda, bu esa barqaror pul oqimini yaratadi. -12.50 qiymati ushbu ko'rsatkichning joriy raqamini ifodalaydi.

Tempus AI, Inc (TEM) - Sof marja 15.06.2024dan 19.11.2026gacha

Tempus AI Inc (TEM) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya kursi va ekspertlarning narx prognozi:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Kompaniyaning jamlanma tahlili:Tempus AI, Inc - TEM
Tempus AI, Inc. yetakchi tovari

Investorlar ushbu ko'rsatkichdan operatsion samaradorlikning barometri va emitentning har bir dollar daromaddan foyda olish qobiliyatini aniqlash uchun foydalanadilar. Sof foyda marjasi orqali aks etgan sof foydaning umumiy savdoga nisbati Tempus AI, Inc (TEM) rahbariyatining genomik ma'lumotlar to'plamlarini monetizatsiya qilish va AI yechimlarini diagnostikaga integratsiya qilish orqali texnologik salohiyatni haqiqiy moliyaviy barqarorlikka aylantirish qobiliyatini tasdiqlaydi.

Raqobatchilar tahlili

qiagen.com (QGEN) - Sof marja|Ionis (IONS) - Sotuvning sof marjinal rentabelligi|Sof marja Repligen|Avidity (RNA) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi CRSP|Kompaniya sotuv marjasi GeneDx|Sof marja Ultragenyx RARE|Kompaniya sotuv marjasi Beam Therapeutics (BEAM)|SRPT: Sof foyda bo'yicha sotuv rentabelligi|Sof marja Twist Bioscience|TXG (10x Genomics) - Sof foyda bo'yicha sotuv rentabelligi|Intellia Therapeutics, Inc. (NTLA) - Sotuvning sof marjinal rentabelligi|Sof marja Stoke Therapeutics Inc|BLFS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi WVE (Wave Life Sciences Corp)|Kompaniya sotuv marjasi Maze Therapeutics Corp|Sionna Therapeutics Inc - Sof foyda bo'yicha sotuv rentabelligi|PRME (primemedicine.com) - Sof foyda marjasi|TSHA - Sof marja|QURE (uniQure) - Sotuvning sof rentabelligi|MeiraGTx Corp (MGTX) - Sof marja|Regenxbio - Sof foyda normasi|Sof marja solidbio.com|Sof marja ocugen.com OCGN|Sotuvning sof marjinal rentabelligi PACB|Benitec - Sotuvning sof rentabelligi|Sof marja Design Therapeutics DSGN|Sotuvning sof marjinal rentabelligi Rocket Pharmaceuticals RCKT|Sof foyda marjasi 4D Molecular Corp|LXEO: Sof marja|KRRO (Korro Bio, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Editas Medicine (EDIT) - Sotuvning sof marjinal rentabelligi|Sof marja Silence Therapeutics Inc.|Sotuvning sof rentabelligi PRQR (proqr.com)|Sof marja Codexis Bio (CDXS)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX